The efficacy of inhaled hypertonic saline for bronchiectasis: a meta-analysis of randomized controlled studies

Xie, Bingfeng; Liu, Ping; Wu, Qi; Xiang, Weineng

doi:10.1016/j.ajem.2020.08.042

Cited by 3 publications

(1 citation statement)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Hypertonic saline can be prescribed to create an osmotic pressure to increase the water content of mucus and reduce its viscosity. However, the efficacy of inhaled hypertonic saline in bronchiectasis is under question with a recent meta-analysis showing no greater effect of hypertonic saline than control (typically isotonic saline) [ 84 ]. Inhaled dry powder mannitol is a therapy with a similar mechanism of action to hypertonic saline, which increases mucus hydration and stimulates coughing.…”

Section: Mucociliary Clearancementioning

confidence: 99%

Precision medicine in bronchiectasis

Pembridge

Chalmers

2021

Breathe

View full text Add to dashboard Cite

Bronchiectasis, due to its highly heterogenous nature, requires an individualised approach to therapy. Patients experience symptoms and exacerbations driven by a combination of impaired mucociliary clearance, airway inflammation and airway infection. Treatment of bronchiectasis aims to enhance airway clearance and to address the underlying causes of inflammation and infection susceptibility. Bronchiectasis has multiple causes and so the pathophysiology leading to individual symptoms and exacerbations are different between individuals. Standardised investigations are recommended by international guidelines to identify the underlying causes of bronchiectasis. The process of identifying the underlying biology within an individual is called “endotyping” and is an emerging concept across chronic diseases. Endotypes that have a specific treatment are referred to as “treatable traits” and a treatable traits approach to managing patients with bronchiectasis in a holistic and evidence-based manner is the key to improved outcomes. Bronchiectasis is an area of intense research. Endotyping allows identification of subsets of patients to allow medicines to be tested differently in the future where trials, rather than trying to achieve a “one size fits all” solution, can test efficacy in subsets of patients where the treatment is most likely to be efficacious.

show abstract

Section: Mucociliary Clearancementioning

confidence: 99%